SuperworthVoyager Therapeutics shares outstanding VYGR
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 60.5M
- On a year earlier
- +3.2%
- more shares
Voyager Therapeutics had 60.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 58.9M | +2% |
| FY2024 | 58M | +15% |
| FY2023 | 50.4M | +31% |
| FY2022 | 38.5M | +2% |
| FY2021 | 37.8M | +1% |
| FY2020 | 37.3M | +1% |
| FY2019 | 36.8M | +14% |
| FY2018 | 32.3M | +10% |
| FY2017 | 29.3M | +15% |
| FY2016 | 25.5M | +3130% |
| FY2014 | 790.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 60.5M | +3% | |
| Q1 FY26 | 59.5M | +2% | |
| Q4 FY25 | 58.9M | +2% | |
| Q3 FY25 | 58.8M | +2% | |
| Q2 FY25 | 58.7M | +2% | |
| Q1 FY25 | 58.3M | +2% | |
| Q4 FY24 | 58M | +15% | |
| Q3 FY24 | 57.9M | +32% | |
| Q2 FY24 | 57.7M | +33% | |
| Q1 FY24 | 57.1M | +35% | |
| Q4 FY23 | 50.4M | +31% | |
| Q3 FY23 | 43.9M | +11% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Voyager Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.